Background Malaria in pregnancy is associated with significant morbidity in pregnant
women and their offspring. Plasmodium falciparum infected erythrocytes (IE) express …

Over 50 million women are exposed to the risk of malaria during pregnancy every year.
Malaria during pregnancy is a leading global cause of maternal morbidity and adverse …

Background Malaria in pregnancy is a major cause of poor maternal and infant health, and
is associated with the sequestration of P. falciparum-infected erythrocytes (IE) in the …

Background In Plasmodium falciparum malaria endemic areas placental malaria (PM) is an
important complication of malaria. The recurrence of malaria in primigravidae women …

Background Pregnancy malaria is caused by Plasmodium falciparum-infected erythrocytes
binding the placental receptor chondroitin sulfate A (CSA). This results in accumulation of …

Pregnant women are particularly susceptible to infection with the malaria parasite
Plasmodium falciparum, with severe consequences for maternal and offspring health …

In areas where Plasmodium falciparum transmission is endemic, clinical immunity against
malaria is progressively acquired during childhood and adults are usually protected against …

Background Pregnancy-associated malaria (PAM) is a serious consequence of Plasmodium
falciparum-infected erythrocytes sequestration in the placenta through the adhesion to the …

Placental malaria is caused by Plasmodium falciparum–infected erythrocytes that bind to
placental tissue. Binding is mediated by VAR2CSA, a parasite antigen coded by the var …

During pregnancy, Plasmodium falciparum-infected erythrocytes (IE) accumulate in the
intervillous spaces of the placenta by binding to chondroitin sulfate A (CSA) and elicit …